We are live on ! Find out more
VEA

Virtus ETF Advisers Portfolio holdings

AUM $215M
1-Year Est. Return 53.68%
This Fund
S&P 500
This Quarter Est. Return
-1.89%
1 Year Est. Return
+53.68%
3 Year Est. Return
+121.72%
5 Year Est. Return
+144.54%
10 Year Est. Return
+633.35%
AUM
$154M
AUM Growth
-$90.8M
Cap. Flow
-$89.2M
Cap. Flow %
-57.92%
Top 10 Hldgs %
20.11%
Holding
827
New
297
Increased
13
Reduced
39
Closed
409

Sector Composition

Rank Sector Weight
1 Financials 21.13%
2 Technology 16.45%
3 Healthcare 14.29%
4 Industrials 11.13%
5 Consumer Discretionary 10.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VKTX icon
726
Viking Therapeutics
VKTX
$3.88B
-1,485
Closed -$59.8K
VMC icon
727
Vulcan Materials
VMC
$36.8B
-4,448
Closed -$1.14M
VNOM icon
728
Viper Energy
VNOM
$8.43B
-3,873
Closed -$190K
VRDN icon
729
Viridian Therapeutics
VRDN
$2.2B
-3,952
Closed -$75.8K
VRT icon
730
Vertiv
VRT
$85.7B
-10,131
Closed -$1.15M
VRTX icon
731
Vertex Pharmaceuticals
VRTX
$123B
-753
Closed -$303K
VVR icon
732
Invesco Senior Income Trust
VVR
$456M
-268,504
Closed -$1.06M
WAB icon
733
Wabtec
WAB
$49.3B
-6,029
Closed -$1.14M
WEC icon
734
WEC Energy
WEC
$36.3B
-1,867
Closed -$176K
WES icon
735
Western Midstream Partners
WES
$19.4B
-4,564
Closed -$175K
WHF icon
736
WhiteHorse Finance
WHF
$138M
-49,129
Closed -$476K
WRB icon
737
W.R. Berkley
WRB
$28.1B
-19,697
Closed -$1.15M
WVE icon
738
Wave Life Sciences
WVE
$1.12B
-5,133
Closed -$63.5K
XENE icon
739
Xenon Pharmaceuticals
XENE
$6.1B
-1,802
Closed -$70.6K
XERS icon
740
Xeris Biopharma Holdings
XERS
$1.45B
-20,910
Closed -$70.9K
XFLT
741
XAI Floating Rate & Alternative Income Trust
XFLT
$282M
-33,408
Closed -$1.11M
XNCR icon
742
Xencor
XNCR
$1.45B
-2,871
Closed -$66K
XYL icon
743
Xylem
XYL
$28.5B
-8,794
Closed -$1.02M
YMAB
744
DELISTED
Y-mAbs Therapeutics
YMAB
-35,789
Closed -$280K
ZLAB icon
745
Zai Lab
ZLAB
$2.07B
-13,086
Closed -$343K
ZNTL icon
746
Zentalis Pharmaceuticals
ZNTL
$332M
-22,713
Closed -$68.8K
ZYME icon
747
Zymeworks
ZYME
$1.62B
-5,633
Closed -$82.5K
AVBP icon
748
ArriVent BioPharma
AVBP
$1.4B
-2,747
Closed -$73.2K
LENZ
749
LENZ Therapeutics
LENZ
$179M
-2,309
Closed -$66.7K
VRN
750
DELISTED
Veren
VRN
-27,462
Closed -$141K

Similar funds

Virtus ETF Advisers's Q1 2025 Portfolio in Review

As of Q1 2025, Virtus ETF Advisers held 827 positions worth $154M, down 37% from $245M the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Virtus ETF Advisers withdrew a net $89.2M in Q1 2025, closing 409 positions and reducing 39 holdings. Its most notable exit was OFS Credit Co, an estimated $2.26M position sold in full.

By sector, the portfolio is most concentrated in Financials at 21% of assets, down from 29% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Virtus ETF Advisers opened a new position in ICICI Bank worth $8.23M.

  • Virtus ETF Advisers's largest Q1 2025 buy was ICICI Bank: 261,046 shares worth $8.23M.
  • Virtus ETF Advisers added most to Microsoft in Q1 2025, an estimated $1.1M increase.
  • Virtus ETF Advisers's biggest Q1 2025 reduction was Fortinet, cutting an estimated $1.33M.
  • Virtus ETF Advisers fully exited OFS Credit Co in Q1 2025, selling an estimated $2.26M.
  • Virtus ETF Advisers's ten largest holdings make up 20% of its $154M portfolio in Q1 2025.
  • Virtus ETF Advisers opened 297 new positions and closed 409 in Q1 2025.
  • Virtus ETF Advisers's portfolio value fell 37% quarter-over-quarter to $154M.

Based on Virtus ETF Advisers's 13F filing for Q1 2025, filed 14 May 2025.